1Ozier Y, Steib A, Ickx B, et al. Haemostatic disorders during liver transplantation. Eur J Anaesthesiol. 2001,18:208-218.
2Segal H, Hunt B J, Cottam S, et al. Fibrinolytic activity during orthotopie liver transplantation with and without aprotinin. Transplantation, 1994, 58: 1356-1360.
3Martin T, Somberg D A, Meng Y G, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med,1997, 127:2885-2888.
4Hourigan L A, Waiters D S, Keck S A, et al. Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients. J Heart Lung Transplant,2002, 21:1283-1289.
5Dmitrewski J, Russel S, Vijeyasingham R, et al. Hematologic problems and organ transplantation. World J Surg, 1996, 20:1160-1165.
6Porte R, Molenaar I Q, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicenenttre randomized double-blind study. Lancet, 2000, 344:1303-1309.
7Hendriks H, Meijier K, DeWolf J T M, et al. Reduced transfusion requirements by recombinant factor Ⅶ a in orthotopic liver transplantation: a pilot study. Transplantation: a pilot study. Transplantation, 2001, 71:402-405.
8Ishitani M, Angel J, Bickston S, et al. laver transplantation: incidence and management of deep venous thrombosis and pulmonary emboli. Transplant Pro,1997, 29:2861-2863.
9Humar A, Johnson E M, Gillingham K J, et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation. Transplantation,1998, 65:229-234.
10Humar A, Key N, Ramcharan T, et al. Kidney retransplants after initial graft loss to vascular thromosls.Clin Transplant, 2001, 15:6-10.
